{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T16:27:57Z","timestamp":1751992077672,"version":"3.37.3"},"reference-count":35,"publisher":"Consilium Medicum","issue":"8","license":[{"start":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T00:00:00Z","timestamp":1665532800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Terapevticheskii arkhiv"],"abstract":"<jats:p>In recent years, the harmonization of domestic and foreign clinical recommendations for the treatment of cystitis has been achieved. Nitrofurans and fosfomycin trometamol are recommended as first line therapy antibiotics, and oral 3rd generation of cephalosporins are recommended as alternative antibiotics; fluoroquinolones are excluded from the recommended medications due to an unfavorable safety profile. The main rationale for inclusion of antibiotics in the recommendations as a first line therapy of cystitis is the level of resistance of uropathogens to antibiotics, primarily Escherichia coli. Stable low level of resistance of E. coli in Russia was noted to nitrofurans and fosfomycin (5%), higher to cephalosporins. Among nitrofurans, furazidine is characterized by higher activity against E. coli compared to nitrofurantoin. The potassium salt of furazidine in dosage form with magnesium carbonate is preferred, since it is characterized by higher bioavailability and provides a therapeutic level of concentrations in urine above the MIC during the entire dosing period. Due to the global increase in the resistance of uropathogens observed in recent years, experts have begun to pay more and more attention to the ecological safety of antimicrobial therapy in order to minimize the risk of concomitant (collateral) damage, contributing to the selection of multi-drug resistant strains of microorganisms. In the latest WHO document of 2021, experts divided antibiotics into three groups (ACCESS, WATCH, RESERVE) according to the priority of choice. The ACCESS group of drugs for the treatment of cystitis includes nitrofurantoin and furazidine as agents with minimal collateral effect, while fosfomycin trometamol and cephalosporins are listed in the WATCH group. Thus, from the standpoint of ecological safety, WHO experts recommend prescribing nitrofurans in the treatment of cystitis in the first line of therapy.<\/jats:p>","DOI":"10.26442\/00403660.2022.08.201775","type":"journal-article","created":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T16:45:33Z","timestamp":1665593133000},"page":"1006-1013","source":"Crossref","is-referenced-by-count":1,"title":["Rationale for choosing an antibiotic for the treatment of cystitis: recommendations of clinical pharmacologists: A review"],"prefix":"10.26442","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7606-8608","authenticated-orcid":false,"given":"Sergey V.","family":"Yakovlev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1389-6454","authenticated-orcid":false,"given":"Margarita P.","family":"Suvorova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18344","published-online":{"date-parts":[[2022,10,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02724-0"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11102817"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.36488\/cmac.2019.2.134-146"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2019.09.008"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/MOU.0000000000000823"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c2096"},{"key":"ref7","unstructured":"\u0421\u0442\u0440\u0430\u0442\u0435\u0433\u0438\u044f \u0438 \u0442\u0430\u043a\u0442\u0438\u043a\u0430 \u0440\u0430\u0446\u0438\u043e\u043d\u0430\u043b\u044c\u043d\u043e\u0433\u043e \u043f\u0440\u0438\u043c\u0435\u043d\u0435\u043d\u0438\u044f \u0430\u043d\u0442\u0438\u043c\u0438\u043a\u0440\u043e\u0431\u043d\u044b\u0445 \u0441\u0440\u0435\u0434\u0441\u0442\u0432 \u0432 \u0430\u043c\u0431\u0443\u043b\u0430\u0442\u043e\u0440\u043d\u043e\u0439 \u043f\u0440\u0430\u043a\u0442\u0438\u043a\u0435: \u0415\u0432\u0440\u0430\u0437\u0438\u0439\u0441\u043a\u0438\u0435 \u043a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u0440\u0435\u043a\u043e\u043c\u0435\u043d\u0434\u0430\u0446\u0438\u0438. \u041f\u043e\u0434 \u0440\u0435\u0434. \u0421.\u0412. \u042f\u043a\u043e\u0432\u043b\u0435\u0432\u0430, \u0421.\u0412. \u0421\u0438\u0434\u043e\u0440\u0435\u043d\u043a\u043e, \u0412.\u0412. \u0420\u0430\u0444\u0430\u043b\u044c\u0441\u043a\u043e\u0433\u043e, \u0422.\u0412. \u0421\u043f\u0438\u0447\u0430\u043a. \u041c.: \u041f\u0440\u0435100 \u041f\u0440\u0438\u043d\u0442, 2016. \u0420\u0435\u0436\u0438\u043c \u0434\u043e\u0441\u0442\u0443\u043f\u0430: http:\/\/antimicrob.net\/wp-content\/uploads\/strategy_201672-1.pdf. \u0421\u0441\u044b\u043b\u043a\u0430 \u0430\u043a\u0442\u0438\u0432\u043d\u0430 \u043d\u0430 26.07.2022 [Strategiia i taktika ratsional'nogo primeneniia antimikrobnykh sredstv v ambulatornoi praktike: Evraziiskie klinicheskie rekomendatsii. Pod red. SV Iakovleva, SV Sidorenko, VV Rafal'skogo, TV Spichak. Moscow: Pre100 Print, 2016. Available at: http:\/\/antimicrob.net\/wp-content\/uploads\/strategy_201672-1.pdf. Accessed: 26.07.2022 (in Russian)]."},{"key":"ref8","unstructured":"\u041f\u0440\u043e\u0433\u0440\u0430\u043c\u043c\u0430 \u0421\u041a\u0410\u0422 (\u0421\u0442\u0440\u0430\u0442\u0435\u0433\u0438\u044f \u041a\u043e\u043d\u0442\u0440\u043e\u043b\u044f \u0410\u043d\u0442\u0438\u043c\u0438\u043a\u0440\u043e\u0431\u043d\u043e\u0439 \u0422\u0435\u0440\u0430\u043f\u0438\u0438) \u043f\u0440\u0438 \u043e\u043a\u0430\u0437\u0430\u043d\u0438\u0438 \u0441\u0442\u0430\u0446\u0438\u043e\u043d\u0430\u0440\u043d\u043e\u0439 \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u043e\u0439 \u043f\u043e\u043c\u043e\u0449\u0438. \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0438\u0435 \u043a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u0440\u0435\u043a\u043e\u043c\u0435\u043d\u0434\u0430\u0446\u0438\u0438. \u041f\u043e\u0434 \u0440\u0435\u0434. \u0421.\u0412. \u042f\u043a\u043e\u0432\u043b\u0435\u0432\u0430, \u041d.\u0418. \u0411\u0440\u0438\u043a\u043e, \u0421.\u0412. \u0421\u0438\u0434\u043e\u0440\u0435\u043d\u043a\u043e, \u0414.\u041d. \u041f\u0440\u043e\u0446\u0435\u043d\u043a\u043e. \u041c.: \u041f\u0435\u0440\u043e, 2018. \u0420\u0435\u0436\u0438\u043c \u0434\u043e\u0441\u0442\u0443\u043f\u0430: http:\/\/nasci.ru\/?id=2880. \u0421\u0441\u044b\u043b\u043a\u0430 \u0430\u043a\u0442\u0438\u0432\u043d\u0430 \u043d\u0430 26.07.2022 [Programma SKAT (Strategiia Kontrolia Antimikrobnoi Terapii) pri okazanii statsionarnoi meditsinskoi pomoshchi. Rossiiskie klinicheskie rekomendatsii. Pod red. SV Iakovleva, NI Briko, SV Sidorenko, DN Protsenko. Moscow: \u00abPero\u00bb, 2018. Available at: http:\/\/nasci.ru\/?id=2880. Accessed: 26.07.2022 (in Russian)]."},{"key":"ref9","unstructured":"\u042f\u043a\u043e\u0432\u043b\u0435\u0432 \u0421.\u0412., \u0421\u0438\u0434\u043e\u0440\u0435\u043d\u043a\u043e \u0421.\u0412., \u0420\u0430\u0444\u0430\u043b\u044c\u0441\u043a\u0438\u0439 \u0412.\u0412. \u0410\u043d\u0442\u0438\u0431\u0438\u043e\u0442\u0438\u043a\u043e\u0440\u0435\u0437\u0438\u0441\u0442\u0435\u043d\u0442\u043d\u043e\u0441\u0442\u044c \u043a\u0430\u043a \u0443\u0433\u0440\u043e\u0437\u0430 \u043d\u0430\u0446\u0438\u043e\u043d\u0430\u043b\u044c\u043d\u043e\u0439 \u0431\u0435\u0437\u043e\u043f\u0430\u0441\u043d\u043e\u0441\u0442\u0438: \u0444\u043e\u043a\u0443\u0441 \u043d\u0430 \u043c\u0435\u0440\u043e\u043f\u0440\u0438\u044f\u0442\u0438\u044f \u0432 \u0430\u043c\u0431\u0443\u043b\u0430\u0442\u043e\u0440\u043d\u043e-\u043f\u043e\u043b\u0438\u043a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u043e\u043c \u0437\u0432\u0435\u043d\u0435 \u0437\u0434\u0440\u0430\u0432\u043e\u043e\u0445\u0440\u0430\u043d\u0435\u043d\u0438\u044f. \u0420\u0435\u0437\u043e\u043b\u044e\u0446\u0438\u044f. \u0412\u0435\u0441\u0442\u043d\u0438\u043a \u043f\u0440\u0430\u043a\u0442\u0438\u0447\u0435\u0441\u043a\u043e\u0433\u043e \u0432\u0440\u0430\u0447\u0430. 2014;3:8-13 [Iakovlev SV, Sidorenko SV, Rafal'skii VV. Antibiotikorezistentnost' kak ugroza natsional'noi bezopasnosti: fokus na meropriiatiia v ambulatorno-poliklinicheskom zvene zdravookhraneniia. Rezoliutsiia. Vestnik prakticheskogo vracha. 2014;3:8-13 (in Russian)]."},{"key":"ref10","unstructured":"WHO Global Strategy for Containment of Antimicrobial Resistance. World Health Organization, 2001. Available at: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/66860\/WHO_CDS_CSR_DRS_2001.2.pdf. Accessed: 26.07.2022."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2900\/2518"},{"key":"ref12","unstructured":"\u0420\u0430\u0441\u043f\u043e\u0440\u044f\u0436\u0435\u043d\u0438\u0435 \u041f\u0440\u0430\u0432\u0438\u0442\u0435\u043b\u044c\u0441\u0442\u0432\u0430 \u0420\u0424 \u043e\u0442 25 \u0441\u0435\u043d\u0442\u044f\u0431\u0440\u044f 2017 \u0433. \u21162045-\u0440 \u00ab\u0421\u0442\u0440\u0430\u0442\u0435\u0433\u0438\u044f \u043f\u0440\u0435\u0434\u0443\u043f\u0440\u0435\u0436\u0434\u0435\u043d\u0438\u044f \u0440\u0430\u0441\u043f\u0440\u043e\u0441\u0442\u0440\u0430\u043d\u0435\u043d\u0438\u044f \u0430\u043d\u0442\u0438\u043c\u0438\u043a\u0440\u043e\u0431\u043d\u043e\u0439 \u0440\u0435\u0437\u0438\u0441\u0442\u0435\u043d\u0442\u043d\u043e\u0441\u0442\u0438 \u0432 \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u043e\u0439 \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u0438 \u043d\u0430 \u043f\u0435\u0440\u0438\u043e\u0434 \u0434\u043e 2030 \u0433\u043e\u0434\u0430\u00bb. \u0420\u0435\u0436\u0438\u043c \u0434\u043e\u0441\u0442\u0443\u043f\u0430: http:\/\/static.government.ru\/media\/files\/onJ3GY3ObDGqLDvrED7AhpLF3ywRRFpp.pdf. \u0421\u0441\u044b\u043b\u043a\u0430 \u0430\u043a\u0442\u0438\u0432\u043d\u0430 \u043d\u0430 26.07.2022 [Rasporiazhenie Pravitel'stva RF ot 25 sentiabria 2017 g. N2045-r \"Strategiia preduprezhdeniia rasprostraneniia antimikrobnoi rezistentnosti v Rossiiskoi Federatsii na period do 2030 goda\". Available at: http:\/\/static.government.ru\/media\/files\/onJ3GY3ObDGqLDvrED7AhpLF3ywRRFpp.pdf. Accessed: 26.07.2022 (in Russian)]."},{"key":"ref13","unstructured":"Naber KG, Bjerklund-Johansen TE, Bishop MC, et al. and the Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU). EAU guidelines for the management of urinary and male genital tract infections. European Association of Urology, 2006. Available at: http:\/\/antibiotic.ru.net\/files\/pdf\/metod\/urology-eau.pdf?ysclid=l6yrfcdet1226530553. Accessed: 26.07.2022."},{"key":"ref14","unstructured":"Grabe M, Bjerklund-Johansen TE, Botto H, et al. Guidelines on urological infections. European association of Urology, 2011. Available at: https:\/\/www.volgmed.ru\/uploads\/files\/2013-3\/17471-urologicheskie_infekcii_2011.pdf. Accessed: 26.07.2022."},{"key":"ref15","unstructured":"Bonkat G, Bartoletti R, Bruyere F, et al. EAU Guidelines on urological infections. European association of Urology, 2022. Available at: https:\/\/d56bochluxqnz.cloudfront.net\/documents\/full-guideline\/EAU-Guidelines-on-Urological-Infections-2022.pdf. Accessed: 26.07.2022."},{"key":"ref16","unstructured":"\u0426\u0438\u0441\u0442\u0438\u0442 \u0431\u0430\u043a\u0442\u0435\u0440\u0438\u0430\u043b\u044c\u043d\u044b\u0439 \u0443 \u0432\u0437\u0440\u043e\u0441\u043b\u044b\u0445. \u041a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u0440\u0435\u043a\u043e\u043c\u0435\u043d\u0434\u0430\u0446\u0438\u0438. \u041c\u0438\u043d\u0438\u0441\u0442\u0435\u0440\u0441\u0442\u0432\u043e \u0437\u0434\u0440\u0430\u0432\u043e\u043e\u0445\u0440\u0430\u043d\u0435\u043d\u0438\u044f \u0420\u0424. \u0420\u0435\u0436\u0438\u043c \u0434\u043e\u0441\u0442\u0443\u043f\u0430: https:\/\/cr.minzdrav.gov.ru\/schema\/14_2. \u0421\u0441\u044b\u043b\u043a\u0430 \u0430\u043a\u0442\u0438\u0432\u043d\u0430 \u043d\u0430 26.07.2022 [Bacterial cystitis in adults. Clinical guidelines. Ministry of Health of the Russian Federation. Available at: https:\/\/cr.minzdrav.gov.ru\/schema\/14_2. Accessed: 26.07.2022 (in Russian)]."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2021.11.008"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2006.05.015"},{"key":"ref19","unstructured":"\u0420\u0430\u0444\u0430\u043b\u044c\u0441\u043a\u0438\u0439 \u0412.\u0412., \u0421\u0442\u0440\u0430\u0447\u0443\u043d\u0441\u043a\u0438\u0439 \u041b.\u0421., \u0411\u0430\u0431\u043a\u0438\u043d \u041f.\u0410., \u0438 \u0434\u0440. \u0420\u0435\u0437\u0438\u0441\u0442\u0435\u043d\u0442\u043d\u043e\u0441\u0442\u044c \u0432\u043e\u0437\u0431\u0443\u0434\u0438\u0442\u0435\u043b\u0435\u0439 \u043d\u0435\u043e\u0441\u043b\u043e\u0436\u043d\u0435\u043d\u043d\u044b\u0445 \u0438\u043d\u0444\u0435\u043a\u0446\u0438\u0439 \u043c\u043e\u0447\u0435\u0432\u044b\u0445 \u043f\u0443\u0442\u0435\u0439 \u0432 \u0420\u043e\u0441\u0441\u0438\u0438. \u0423\u0440\u043e\u043b\u043e\u0433\u0438\u044f. 2006;5:34-37 [Rafal\u2019skii VV, Strachunskii LS, Babkin PA, et al. Resistance of causative agents of uncomplicated urinary tract infections in Russia. Urologiia. 2006;5:34-37 (in Russian)]."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2009.04.012"},{"key":"ref21","unstructured":"\u041f\u0430\u043b\u0430\u0433\u0438\u043d \u0418.\u0421., \u0421\u0443\u0445\u043e\u0440\u0443\u043a\u043e\u0432\u0430 \u041c.\u0412., \u0414\u0435\u0445\u043d\u0438\u0447 \u0410.\u0412., \u0438 \u0434\u0440. \u0421\u043e\u0432\u0440\u0435\u043c\u0435\u043d\u043d\u043e\u0435 \u0441\u043e\u0441\u0442\u043e\u044f\u043d\u0438\u0435 \u0430\u043d\u0442\u0438\u0431\u0438\u043e\u0442\u0438\u043a\u043e\u0440\u0435\u0437\u0438\u0441\u0442\u0435\u043d\u0442\u043d\u043e\u0441\u0442\u0438 \u0432\u043e\u0437\u0431\u0443\u0434\u0438\u0442\u0435\u043b\u0435\u0439 \u0432\u043d\u0435\u0431\u043e\u043b\u044c\u043d\u0438\u0447\u043d\u044b\u0445 \u0438\u043d\u0444\u0435\u043a\u0446\u0438\u0439 \u043c\u043e\u0447\u0435\u0432\u044b\u0445 \u043f\u0443\u0442\u0435\u0439 \u0432 \u0420\u043e\u0441\u0441\u0438\u0438: \u0440\u0435\u0437\u0443\u043b\u044c\u0442\u0430\u0442\u044b \u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u043d\u0438\u044f \u00ab\u0414\u0410\u0420\u041c\u0418\u0421\u00bb (2010\u20132011). \u041a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0430\u044f \u043c\u0438\u043a\u0440\u043e\u0431\u0438\u043e\u043b\u043e\u0433\u0438\u044f \u0438 \u0430\u043d\u0442\u0438\u043c\u0438\u043a\u0440\u043e\u0431\u043d\u0430\u044f \u0445\u0438\u043c\u0438\u043e\u0442\u0435\u0440\u0430\u043f\u0438\u044f. 2012;14(4):280-303 [Palagin S, Sukhorukova MV, Dekhnich AV, et al. Current state of antibiotic resistance of pathogens causing community-acquired urinary tract infections in Russia: \"DARMIS\" Study (2010\u20132011). Clinical Microbiology and Antimicrobial Chemotherapy. 2012;14(4):280-303 (in Russian)]."},{"key":"ref22","unstructured":"MIC and zone diameter distributions and ECOFFs. Available at: https:\/\/www.eucast.org\/mic_distributions_and_ecoffs\/ Accessed: 26.07.2022."},{"key":"ref23","unstructured":"MARAN 2009. Monitoring of antimicrobial resistance and antibiotic usage in animals in the Netherlands in 2009. Available at: http:\/\/edepot.wur.nl\/165958. Accessed: 26.07.2022."},{"key":"ref24","unstructured":"\u0420\u0430\u043c\u0435\u043d\u0441\u043a\u0430\u044f \u0413.\u0412. \u0418\u0437\u0443\u0447\u0435\u043d\u0438\u0435 \u0441\u0440\u0430\u0432\u043d\u0438\u0442\u0435\u043b\u044c\u043d\u043e\u0439 \u0444\u0430\u0440\u043c\u0430\u043a\u043e\u043a\u0438\u043d\u0435\u0442\u0438\u043a\u0438 \u043f\u0440\u0435\u043f\u0430\u0440\u0430\u0442\u043e\u0432 \u0424\u0443\u0440\u0430\u043c\u0430\u0433 \u0438 \u0424\u0443\u0440\u0430\u0433\u0438\u043d. \u0418\u043d\u0444\u0435\u043a\u0446\u0438\u0438 \u0438 \u0430\u043d\u0442\u0438\u043c\u0438\u043a\u0440\u043e\u0431\u043d\u0430\u044f \u0442\u0435\u0440\u0430\u043f\u0438\u044f. 2004;6(1):34 [Ramenskaia GV. Izuchenie sravnitel'noi farmakokinetiki preparatov furamag i furagin. Infektsii i antimikrobnaia terapiia. 2004;6(1):34 (in Russian)]."},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.18565\/urology.2021.4.97-105"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.03.001"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1586\/eri.10.14"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2019.10.008"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv062"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2014.11.016"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq257"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000000296"},{"key":"ref33","unstructured":"The selection and use of essential medicines. Report of the WHO Expert Committee on Selection and Use of Essential Medicines, 2017 (including the 20th WHO Model List of Essential Medicines and the 6th WHO Model List of Essential Medicines for Children). Available at: http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/259481\/9789241210157-eng.pdf;jsessionid=B30EB53483079A0031CFAC1708FE542E?sequence=1. Accessed: 26.07.2022."},{"key":"ref34","unstructured":"The 2019 WHO AWaRe classification of antibiotics for evaluation and monitoring of use. Available at: https:\/\/apps.who.int\/iris\/handle\/10665\/327957. Accessed: 26.07.2022."},{"key":"ref35","unstructured":"AWaRe classification. WHO access, watch, reserve, classification of antibiotics for evaluation and monitoring of use. Available at: https:\/\/www.who.int\/publications\/i\/item\/2021-aware-classification. Accessed: 26.07.2022."}],"container-title":["Terapevticheskii arkhiv"],"original-title":[],"link":[{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/111838\/86611","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/111838\/86611","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T16:46:36Z","timestamp":1665593196000},"score":1,"resource":{"primary":{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/view\/111838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,12]]},"references-count":35,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,10,12]]}},"URL":"https:\/\/doi.org\/10.26442\/00403660.2022.08.201775","relation":{},"ISSN":["2309-5342","0040-3660"],"issn-type":[{"type":"electronic","value":"2309-5342"},{"type":"print","value":"0040-3660"}],"subject":[],"published":{"date-parts":[[2022,10,12]]}}}